T 2735/19 (TAS-102 administration/TAIHO) of 19.07.2023

European Case Law Identifier: ECLI:EP:BA:2023:T273519.20230719
Date of decision: 19 July 2023
Case number: T 2735/19
Petition for review of: -
Application number: 06712292.9
IPC class: A61K 31/7072 A61K 31/7068 A61K 31/506 A61P 35/00 A61K 31/513
Language of proceedings: English
Distribution: No distribution (D)
Download: Decision in English
OJ versions: No OJ links found
Other decisions for this case: -
Abstracts for this decision: -
Application title: ANTICANCER DRUG CONTAINING ALPHA, ALPHA, ALPHA-TRIFLUOROTHYMIDINE AND THYMIDINE PHOSPHORYLASE INHIBITOR
Applicant name: Taiho Pharmaceutical Co., Ltd.
Opponent name: STADA Arzneimittel AG
Generics (U.K.) Limited
Board: 3.3.07
Headnote: -
Relevant legal provisions: European Patent Convention Art 56 European Patent Convention Art 83
Keywords: Inventive step - (yes) unexpected improvement shown
Sufficiency of disclosure - (yes)
Catchword: -
Cited cases: G 0003/14 G 0002/21
Citing cases: T 1993/23

Order

For these reasons it is decided that:

The appeals are dismissed.